Delivery Order SPE2DE21D7020-SPE2D626F892J
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on December 5, 2025, with an ultimate completion date of December 12, 2025, is designated as a fixed-price delivery order with economic price adjustment provisions. This award is issued without small business set-aside restrictions, allowing Boston Scientific to compete on an unrestricted...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $26,078.40 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on November 17, 2025, with an ultimate completion date of November 20, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $23,660 under the Defense Health Agency's Medical Supply Chain Blanket Purchase Agreement on August 25, 2025, with an ultimate completion date of September 2, 2025. The contract employs fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's single-award BPA with the Defense...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division, effective October 24, 2025, with an ultimate completion date of October 31, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing single-award...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,085.40 under a fixed-price contract with economic price adjustment provisions by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on November 6, 2025, with an ultimate completion date of November 14, 2025, represents a continuation of Boston Scientific's established role as a critical supplier of specialized radiation oncology equipment and...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,325.89 under a Defense Health Agency Medical Supply Chain blanket purchase agreement (BPA). The contract, awarded on December 2, 2025, with an ultimate completion date of December 9, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The delivery order is part of a larger single-award BPA valued at $750,000 that was established on March...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $14,856.64 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment capability is set to be completed by November 10, 2025, and represents a delivery order against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency. The contract involves the provision of specialized medical devices and...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $4,048 delivery order by the Defense Health Agency's Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 4, 2025. This delivery order operates under a fixed-price contract with economic price adjustment terms and is issued against a larger single-award Blanket Purchase Agreement valued at $750,000, which designates Boston Scientific as the sole...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $4,235.60 by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on October 29, 2025, with an ultimate completion date of November 5, 2025, is characterized by fixed-price pricing with economic price adjustment terms. This award represents a task order issued against Boston Scientific's single-award Blanket Purchase Agreement with the Defense Health...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,580.66 by the Defense Health Agency's Medical Supply Chain division on October 24, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, is scheduled for completion by October 31, 2025. This delivery order is issued without a small business set-aside, allowing Boston Scientific to compete on an...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F892JDelivery Order
Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,206.30 by the Defense Health Agency's Medical Supply Chain division under a single-award Blanket Purchase Agreement (BPA) with a $750,000 ceiling. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 15, 2025, represents a fixed-price contract with economic price adjustment provisions. This award is issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The contract involves the supply of radiation treatment devices, specifically supporting the Defense Health Agency's procurement of specialized radiation oncology equipment and related technologies for military healthcare facilities and Veterans Affairs medical centers. This delivery order exemplifies Boston Scientific's established role as a critical supplier of complex medical devices to federal healthcare entities. The company's BPA with the Defense Health Agency, effective through March 30, 2030, streamlines the procurement process for Y-90 glass microspheres, radiopharmaceuticals, and related radiation treatment technologies essential for cancer care across the defense and veterans healthcare enterprises. As a global medical technology company with extensive experience fulfilling federal contracts across multiple therapeutic areas—including cardiovascular, interventional, diagnostic, and neuromodulation devices—Boston Scientific continues to demonstrate its capability to maintain supply chain continuity for specialized medical technologies critical to federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 12/7/25 |